Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.japh.2020.06.004 http://scihub22266oqcxt.onion/10.1016/j.japh.2020.06.004 32593633!7294253!32593633     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32593633&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Am+Pharm+Assoc+(2003) 2020 ; 60 (6): e76-e79 Nephropedia Template TP {{tp|p=32593633|t=2020. Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic |pdf=|usr=}}{{32593633}} gab.com Text Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic JO: J Am Pharm Assoc (2003) http://www.kidney.de/pget.php?&tw=1&pmid=32593633 #FOAvip The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medicaid Services provide reimbursement for these services. Reimbursement options remain open to pharmacists, but depend on local regulation or the ability to alter practice at the site. Though pharmacists provide high-quality direct patient care, they are excluded from seeking compensation for providing this care, even as the nation expands the telehealth model. This overview shows that despite changes in telehealth service compensation for health care providers, pharmacists remain unable to seek appropriate compensation for their direct patient care services. Twit Text FOAVip Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic ????J Am Pharm Assoc (2003) http://www.kidney.de/pget.php?&tw=1&pmid=32593633 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32593633 #FOAvip English Wikipedia <ref>{{Cite pmid|32593633}}</ref> Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic #MMPMID32593633 Pritchard RI; Huff J; Scheinberg N J Am Pharm Assoc (2003) 2020[Nov]; 60 (6): e76-e79 PMID32593633show ga The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medicaid Services provide reimbursement for these services. Reimbursement options remain open to pharmacists, but depend on local regulation or the ability to alter practice at the site. Though pharmacists provide high-quality direct patient care, they are excluded from seeking compensation for providing this care, even as the nation expands the telehealth model. This overview shows that despite changes in telehealth service compensation for health care providers, pharmacists remain unable to seek appropriate compensation for their direct patient care services. |*COVID-19 Drug Treatment[MESH] |*Government Regulation[MESH] |COVID-19/epidemiology[MESH] |Centers for Medicare and Medicaid Services, U.S.[MESH] |Humans[MESH] |Pharmacists/*economics/legislation & jurisprudence/organization & administration[MESH] |Professional Role[MESH] |Reimbursement Mechanisms/*legislation & jurisprudence[MESH] |SARS-CoV-2[MESH] |Telemedicine/*economics/legislation & jurisprudence/organization & administration[MESH]Impact of regulatory changes on pharmacist-delivered telehealth during(epmc).pdf DeepDyve Pubget Overpricing